Suomi - suomi - Fimea (Suomen lääkevirasto)

lohmann animal health gmbh - kanan herpes simplex-virus tyyppi, rispens, elävä - injektiokonsentraatti - marekin tauti -rokote

Suomi - suomi - Fimea (Suomen lääkevirasto)

lohmann animal health gmbh - kanan herpes simplex-virus tyyppi, rispens, elävä - suspensio ja liuotin injektionestettä varten, suspensio - marekin tauti -rokote

Suomi - suomi - Fimea (Suomen lääkevirasto)

ceva-phylaxia veterinary biologicals co. ltd. - marek's disease virus, serotype 1, cvi-988 - injektiokonsentraatti ja liuotin, suspensiota varten - marekin tauti -rokote

Euroopan unioni - suomi - EMA (European Medicines Agency)

intervet international b.v. - solu-liittyvät live rekombinantti kalkkunan herpesvirus (kanta hvp360), ilmaista fusion proteiini nd virus ja vp2 proteiini ibd-viruksen - lintuinfluenssan herpes virus (marek ' s disease) + lintuinfluenssan gumboron tautiviruksen (gumboro-tauti) + newcastlen tauti-viruksen/paramyksoviruksen - chicken; embryonated chicken eggs - for active immunisation of one-day-old chicks or 18-19-day-old embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to prevent mortality and to reduce clinical signs and lesions caused by infectious bursal disease (ibd) virus,to reduce mortality, clinical signs and lesions caused by marek’s disease (md) virus.

Euroopan unioni - suomi - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - kana - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.

Euroopan unioni - suomi - EMA (European Medicines Agency)

ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - immunologiset lääkkeet - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).

Euroopan unioni - suomi - EMA (European Medicines Agency)

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - immunologiset lääkkeet - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Euroopan unioni - suomi - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - split influenssa virus, inaktivoitu, sisältää antigeenia*: a/california/7/2009 (h1n1)v-kaltainen kanta (x-179a)*tuotettu kananmunissa. - influenza, human; immunization; disease outbreaks - influenssarokot - influenssan ennaltaehkäisy virallisesti ilmoitetussa pandemiatilanteessa. pandemian influenssarokote on käytettävä virallisten ohjeiden mukaisesti.

Euroopan unioni - suomi - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - koko seuraavasta, inaktivoitu, sisältää antigeenia*: a/vietnam/1194/2004 (h5n1)* tuotettu kananmunissa - influenza, human; immunization; disease outbreaks - rokotteet - influenssan ennaltaehkäisy virallisesti ilmoitetussa pandemiatilanteessa. pandemian influenssarokote on käytettävä virallisten ohjeiden mukaisesti.

Euroopan unioni - suomi - EMA (European Medicines Agency)

sanofi pasteur s.a. - split influenssa virus, inaktivoitu, sisältää antigeenia*: a/california/7/2009 (h1n1)v-kaltainen kanta (x-179a)*tuotettu kananmunissa. - influenza, human; immunization; disease outbreaks - rokotteet - influenssan ennaltaehkäisy virallisesti ilmoitetussa pandemiatilanteessa. pandemian influenssa rokotetta tulee käyttää virallisen ohjeistuksen mukaisesti.